- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04827511
Refractive Disorders and Seric Vitamin D Level in Children With Disabilities (REDIC)
April 1, 2021 updated by: Holhos Larisa Bianca
The investigator want to determine the refractive status of 80 children with disabilities and of 81 healthy children from a witness group.
The vitamin D level of the children will be dosed for making different correlations with visual acuity status.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Refraction measurement will be done by the investigator in all 161 children.
Visual acuity is checked, initial and after correction with proper correction.
Vitamin D level is dosed from all the children in order to make correlations with the visual acuity, refractive status and risk for visual impairment.
Study Type
Observational
Enrollment (Actual)
161
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bihor
-
Marghita, Bihor, Romania, 415300
- Holhoș Larisa Bianca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 16 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
80 children with disabilities like ADHD, autism, Down syndrome, deafness, phocomelia and 81 clinically healthy children
Description
Inclusion Criteria:
- children with disabilities and healthy children
Exclusion Criteria:
- children diagnosed with another chronic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cohort group
80 children with disabilities like autism, ADHD, Down syndrome, deafness, phocomelia, dyslexia, different motor problems
|
Refractive measurement and vitamin D level dosing
|
|
control group
81 healthy children, not known or diagnosed with a chronic disease of any kind
|
Refractive measurement and vitamin D level dosing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Refractive disorders in children with disabilities
Time Frame: 1 January 2019-31 August 2020
|
Prevalence of refractive disorders in children with disabilities
|
1 January 2019-31 August 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Holhoș L Bianca, Doctor, Faculty of Medicine and Pharmacy Oradea
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Actual)
August 31, 2020
Study Completion (Actual)
March 31, 2021
Study Registration Dates
First Submitted
March 30, 2021
First Submitted That Met QC Criteria
March 30, 2021
First Posted (Actual)
April 1, 2021
Study Record Updates
Last Update Posted (Actual)
April 5, 2021
Last Update Submitted That Met QC Criteria
April 1, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 142312202069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Reports from the statistical analysis
IPD Sharing Time Frame
20/10/2021-20/10/2031
IPD Sharing Access Criteria
by invitation
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child, Only
-
Riphah International UniversityRecruiting
-
Riphah International UniversityRecruiting
-
Riphah International UniversityRecruiting
-
Riphah International UniversitySponsor GmbHCompleted
-
University of Las Palmas de Gran CanariaCompleted
-
Riphah International UniversityRecruiting
-
Universidade Federal de Santa MariaSuspended
-
Istanbul UniversityRecruiting
-
Igdir UniversityCompletedHealthy | Child, OnlyTurkey
-
Xinhua Hospital, Shanghai Jiao Tong University...Active, not recruitingADHD | Child, OnlyChina
Clinical Trials on Refraction measurement with auto-ref-keratometer Canon
-
Essilor InternationalRecruitingAccommodation Disorder | Accommodative Fatigue | Accommodative InertiaFrance
-
University Hospital OlomoucPalacky UniversityCompleted